Pen Needles Market Size, Share, Analysis Report

1    INTRODUCTION    
   1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources
 

2 Research Methodology 
    2.1 Research Methodology Steps 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology 
    2.4 Research Design 
    2.5 Market Data Validation and Triangulation 
    2.6 Assumptions for the Study

3 Executive Summary 
    3.1 Introduction 
    3.2 Current Scenario 
    3.3 Future Outlook 
    3.4 Conclusion

4 Premium Insights 
    4.1 Market Overview 
    4.2 Geographic Analysis: Market, By Length 
    4.3 Market, By Type 
    4.4 Market, By Length 
    4.5 Market, By Mode of Purchase 
    4.6 Geographic Snapshot: Market

5 Market Overview 
    5.1 Introduction 
    5.2 Market Segmentation 
    5.3 Market Dynamics 
           5.3.1 Drivers
                    5.3.1.1 Favorable Reimbursement Environment and Government Support in Selected Countries
                    5.3.1.2 Advantages of Insulin Pens Over Syringes and Vials
                    5.3.1.3 Technological Advancements
                    5.3.1.4 Growing Diabetic Population
                    5.3.1.5 Conferences, Meetings, and Congresses to Create Pen Needle Awareness
           5.3.2 Restraints
                    5.3.2.1 Poor Reimbursement Structure in Developing Countries
                    5.3.2.2 Needle Anxiety
                    5.3.2.3 Alternative Drug Delivery Methods
                               5.3.2.3.1 Oral Diabetic Agents and Oral Insulin
                               5.3.2.3.2 Inhalable Insulin
                               5.3.2.3.3 Nanotechnology to Aid in Transdermal and Inhalational Route of Administering Proteins and Peptides
                    5.3.2.4 Severe Shortage of Endocrinologists in the U.S.
                    5.3.2.5 Reuse of Pen Needles
           5.3.3 Opportunities
                    5.3.3.1 Safety Needles
                    5.3.3.2 GLP-1 Analogues
           5.3.4 Challenges
                    5.3.4.1 Minimizing the Reuse of Standard Pen Needles
                    5.3.4.2 Resistance Against Switching From Conventional Devices to Advanced Devices

6 Industry Insights 
    6.1 Introduction 
    6.2 Porter’s Five Forces Analysis 
           6.2.1 Threat of New Entrants
           6.2.2 Bargaining Power of Suppliers
           6.2.3 Bargaining Power of Buyers
           6.2.4 Segment Rivalry
           6.2.5 Threat of Substitutes
    6.3 Competitive Intensity 
           6.3.1 Evaluation Parameters
           6.3.2 Scoring Methodology
           6.3.3 Competitive Intensity Score, By Company
                    6.3.3.1 Competitive Intensity Score for BD
                    6.3.3.2 Competitive Intensity Score for Novo Nordisk
                    6.3.3.3 Competitive Intensity Score for Ypsomed
           6.3.4 Competitive Intensity Mapping of BD, Novo Nordisk, and Ypsomed
           6.3.5 Comparison of Evaluation Parameters, By Company
                    6.3.5.1 Pricing
                    6.3.5.2 Product Portfolio
                    6.3.5.3 Product Launches/Technological Advancements
                    6.3.5.4 Production Capacity (2015)
                    6.3.5.5 Geographical Presence
                    6.3.5.6 Promotional/Marketing Activities
                    6.3.5.7 Sponsorships/Donations/Education/Awareness Campaigns
                    6.3.5.8 M&As, Partnerships, Collaborations, Agreements, and Expansions
                    6.3.5.9 Years of Experience
                    6.3.5.10 Certifications/Accreditations/Awards

7 Pen Needles Market, By Type 
    7.1 Introduction 
    7.2 Standard Pen Needles 
    7.3 Safety Pen Needles

8 Pen Needles Market, By Needle Length 
    8.1 Introduction 
    8.2 4mm 
    8.3 5mm 
    8.4 6mm 
    8.5 8mm 
    8.6 10mm 
    8.7 12mm

9 Pen Needles Market, By Therapy 
    9.1 Introduction 
    9.2 Insulin 
    9.3 GLP-1 
    9.4 Growth Hormones

10 Pen Needles Market, By Mode of Purchase 
     10.1 Introduction 
     10.2 Retail 
     10.3 Non-Retail

11 Pen Needles Market, By Region 
     11.1 Introduction 
     11.2 North America 
             11.2.1 U.S.
                        11.2.1.1 Growing Diabetes Prevalence and Favorable Reimbursement Scenario for Pen Needles
                        11.2.1.2 Federal Initiatives to Stimulate the U.S. Pen Needles Market
                        11.2.1.3 Focus of Leading Players on Increasing Market Penetration in the U.S.
                        11.2.1.4 Improvements in Pen Needle Technologies to Eliminate Needlestick Injuries
                        11.2.1.5 Low Penetration of Pen Injectors in the U.S. as Compared to Europe
             11.2.2 Canada
                        11.2.2.1 High Diabetes Prevalence
                        11.2.2.2 Regulations for the Use of Safety-Engineered Needles
                        11.2.2.3 Government Support for Pen Needles in Alberta
     11.3 Europe 
             11.3.1 Germany
                        11.3.1.1 Regulatory Framework to Minimize Needlestick Injuries & Boost Use of Safety-Engineered Devices
                        11.3.1.2 High Diabetes Prevalence and Reimbursement for Pen Needles
             11.3.2 U.K.
                        11.3.2.1 Activities to Pool Funds for Diabetes Care & Research
             11.3.3 France
                        11.3.3.1 Conferences and Exhibitions to Increase Exposure for Pen Needles Players in French Market
                        11.3.3.2 Higher Insurance Coverage and Increase in Aging Population and Affordability
             11.3.4 Italy
                        11.3.4.1 Wide Regional Variations in Terms of Benefits and Coverage to Slow Growth in Italy
                        11.3.4.2 Awareness Campaigns for Diabetes in Italy to Propel the Market Growth
             11.3.5 Spain
                        11.3.5.1 Large Pool of Diabetic Population, Regulations Mandating the Use of Safety Pen Needles
             11.3.6 Rest of Europe
                        11.3.6.1 High Diabetes Prevalence in Russia, Poland, Romania, and Ukraine
     11.4 Asia 
             11.4.1 Japan
                        11.4.1.1 High Adoption of Insulin Pens and Approval of Injectable Insulin
             11.4.2 China
                        11.4.2.1 Growing Presence of Global and Local Players in China
                        11.4.2.2 High Diabetes Incidence and Adoption of Insulin Pens
                        11.4.2.3 High Reuse Rate & Lack of Reimbursement to Limit Market Growth
             11.4.3 India
                        11.4.3.1 Growing Presence of Global Players in India
                        11.4.3.2 Low Pen Needle Penetration, Lack of Awareness to Restrain Market Growth
             11.4.4 Rest of Asia
                        11.4.4.1 Vietnam, A Potential Market for Pen Needles
                        11.4.4.2 Increase in Pen Needles Likely in Singapore & Malaysia
     11.5 Rest of the World (RoW) 
             11.5.1 Latin America
                        11.5.1.1 Increasing Diabetic Population and Rising Awareness on Diabetes in Brazil
             11.5.2 Pacific Countries
                        11.5.2.1 Amendments in Ndss to Increase Access to Diabetic Products in Australia
                        11.5.2.2 Favorable Reimbursement Scenario and Presence of Charity Organizations in New Zealand
             11.5.3 Middle East & Africa
                        11.5.3.1 Presence of Local & International Pen Needle Manufacturers and Rising Awareness on Pen Needles to Bolster the Market
                        11.5.3.2 Increasing Diabetic Population, Rising Awareness on Diabetes

12 Pen Needle Distributor List 

13 Competitive Landscape 
     13.1 Overview 
     13.2 Market Share Analysis 
             13.2.1 Introduction
             13.2.2 Becton, Dickinson & Co.
             13.2.3 Novo Nordisk A/S
             13.2.4 Ypsomed Holding AG
             13.2.5 Others
     13.3 Competitive Situation and Trends 
             13.3.1 Marketing and Promotion
             13.3.2 Expansion
             13.3.3 Product Launch
             13.3.4 Others

14 Company Profiles
     14.1 Introduction 
     14.2 Becton, Dickinson and Company 
     14.3 Novo Nordisk A/S 
     14.4 Ypsomed Holding AG 
     14.5 Owen Mumford, Ltd. 
     14.6 HTL-Strefa S.A. 
     14.7 B. Braun Melsungen 
     14.8 Terumo Corporation 
     14.9 Ultimed, Inc. (LDI, Ltd.) 
     14.10 Allison Medical, Inc. 
     14.11 Artsana S.P.A.

The Global Pen Needles Market has been segmented as below:

By Product Analysis:

• Standard Pen Needles
• Safety Pen Needles

By Length Analysis:

• 4mm
• 5mm
• 6mm
• 8mm
• 10mm
• 12mm

By Therapy Analysis:

• Insulin
• Glucagon-like-Peptide-1 (GLP-1)
• Growth Hormone

By Regional Analysis:

• North America
• Europe
• Asia-Pacific
• Rest of the World